Magnesium Sulfate Dilution and Administration
Magnesium sulfate should be diluted in either 5% Dextrose Injection (D5W) or 0.9% Sodium Chloride Injection (normal saline) for intravenous administration. 1
FDA-Approved Diluent Options
The FDA label for magnesium sulfate specifies two compatible IV fluids for dilution 1:
- 5% Dextrose Injection, USP (D5W)
- 0.9% Sodium Chloride Injection, USP (normal saline)
Both solutions are equally acceptable and the choice depends on the clinical scenario and patient's metabolic needs 1.
Standard Dilution Protocols
For Severe Hypomagnesemia
- Add 5 g magnesium sulfate (approximately 40 mEq) to 1 liter of either D5W or normal saline 1
- Infuse slowly over a 3-hour period 1
For Pre-eclampsia/Eclampsia
- Dilute 4-5 g magnesium sulfate in 250 mL of either D5W or normal saline 1
- Alternatively, dilute the 50% solution to a 10% or 20% concentration (40 mL of 10% solution or 20 mL of 20% solution) and inject IV over 3-4 minutes 1
For Parenteral Nutrition
- Magnesium sulfate can be added directly to parenteral nutrition solutions with few compatibility issues 2
- The ESPGHAN/ESPEN guidelines note that magnesium sulfate has superior compatibility compared to magnesium chloride, which increases anion gap and metabolic acidosis risk 2
Critical Mixing Requirements
Adequate mixing is absolutely essential before administration. 3 A 1983 study demonstrated that failure to properly mix magnesium sulfate added to IV fluids results in dangerously high concentrations in the initial aliquot—up to 1,145.7 mM/liter in the first 10 cc when 24.5 mM was added to 1 liter 3.
Mixing Protocol
- Perform at least three complete inversions of the IV bag after adding magnesium sulfate to ensure adequate dispersion 3
- Consider color-coding additives with harmless dye to alert personnel to inadequate mixing 3
- Visually inspect for particulate matter and discoloration before administration 1
Compatibility Considerations
Compatible in Parenteral Nutrition
- Magnesium sulfate mixes well with amino acids and glucose solutions in PN formulations 2
- When calcium and phosphate are used at upper dosing ranges, stability testing by the pharmacy is required to prevent precipitation 2
Incompatible Solutions - Do Not Mix
- Calcium-containing solutions: Risk of calcium-phosphate precipitation 4
- Sodium bicarbonate: Can inactivate catecholamines and cause precipitation 4
- Sodium phosphate: Must use separate IV access points; never mix in same solution or administer through same line simultaneously 4
Antibiotic Interactions
- Magnesium may reduce antibiotic activity of streptomycin, tetracycline, and tobramycin when given together 1
- Use separate IV lines when administering these antibiotics concurrently 1
Alternative Administration Routes
Ringer's Lactate Solution
- While not specifically listed in the FDA label, magnesium sulfate has been administered in Ringer's lactate solution for tocolysis 5
- However, this resulted in massive solute diuresis (>18L in 48 hours), with magnesium sulfate contributing 30% of urinary solute 5
- Caution: This combination may be less ideal due to enhanced diuretic effect 5
Subcutaneous Administration
- For chronic hypomagnesemia in ambulatory patients, subcutaneous magnesium sulfate (typically 4 mmol added to saline bags) can be effective 6
- A systematic review identified 14 reports demonstrating safety and efficacy of subcutaneous administration 6
- This route is particularly useful for patients with high-output stomas requiring long-term management 6
Common Pitfalls to Avoid
- Never administer undiluted 50% magnesium sulfate IV rapidly: This can cause severe hypotension, cardiac arrest, and respiratory depression 1
- Always mix thoroughly: Inadequate mixing creates lethal concentrations in initial fluid 3
- Check renal function first: Maximum dose is 20 g/48 hours in severe renal insufficiency with frequent serum monitoring 1
- Avoid prolonged use in pregnancy: Continuous use beyond 5-7 days can cause fetal abnormalities 1